Objective: To examine the influence of maternal HbA1c level at delivery and risk of hypoglycemia in infants of diabetic mothers.
Introduction
In 2010, the International Diabetes Federation (IDF) estimated that 5.7 million (6.1%) and 6.7 million (7.1%) of people living in Bangladesh is suffering from diabetes and impaired glucose tolerance (IGT) respectively 1 .
Diabetes is a fairly common medical complication of pregnancy associated with maternal, foetal and neonatal morbidities and mortalities. The gestational diabetes mellitus (GDM) is seen in almost 80%, whereas around 12-15% has pregestational diabetes 2 .
Poor metabolic control of maternal diabetes during the first trimester is associated with foetal malformations, during the second and third trimester with metabolic derangement in the neonatal period 3 .
Newborn IDMs are hyperinsulinemic due to pancreatic beta-cell hyperplasia induced by chronic maternal hyperglycemia and the neonatal hypoglycemia seems to result from this together with disorders of both catecholamine and glucagon response and have a diminished capability to mount compensatory response to hypoglycemia like glycogenolysis, gluconeogenesis and for utilizing alternative substrates 4 . Hypoglycemia in IDMs mostly asymptomatic. However, the absence of overt symptoms at low blood glucose levels does not rule out central nervous system injury 5 .Moreover hyperinsulinemic hypoglycemia is a major risk factor for brain injury and subsequent neurodevelopmental handicap, the identification, rapid diagnosis and prompt management of patients with hyperinsulinemia is essential if brain damage is to be avoided 6 .
It would be useful, therefore, if we could predict postnatal hypoglycaemia from the state of maternal glycemic control. Glycosylated hemoglobin reflects the glycemic control over preceeding 7-8 weeks 7 . Kline The present study was undertaken to examine the influence of maternal HbA1c and risk of hypoglycemia in babies born to diabetic mothers. Blood glucose value of less than 2.6 mmol/l was considered as neonatal hypoglycemia 10 . Exclusion criteria were IDMs with major congenital malformation at birth, severe perinatal asphyxia, and severe erythroblastosis foetalis.
Materials and methods
Blood glucose level of IDMs was measured by Precision-plus (MediSense, USA) glucometer using glucose oxidase method at birth in cord blood, and thereafter at bed side blood sample obtained from heelprick. Maternal glycemic status was measured by HbA1c at delivery by HPLC (High Performance Liquid Chromatography) method at BIRDEM using Bio-Rad Variant Analyzer (USA) and level of <6 % considered as good control 9 . Results were analyzed by employing Stastistical Package for Social Science (SPSS Version 11.0) software package. 2 . The predominance of pregestational diabetes over GDM in this study could be accounted for women being registered at BIRDEM at diagnosis of DM. Pregnancy itself is diabetogenic, the flow of fuels to the fetus is mediated by the sequential rise of hormones, which are diabetogenic 11 . Insulin requirement increases with each trimester of pregnancy in diabetic women 12 . In the present study majority of mothers in both cases (80%) and controls (76.7%) required treatment with insulin. So, modality of treatment is also an indicator of severity of glycemic status during pregnancy. Hypoglycemia was detected by 6 hours of age in 73.3% cases; 50% at 4 hours of age, 23.3% at 6 hours of age. At 8 hours and also at 12 hours of age hypoglycemia was detected only in 16.6% of cases.
Results

Table-I
Characteristics of mothers and newborns
Characteristics of mothers
The nadir in IDM's blood glucose usually occurs between 1 and 4 hours of life 4 . Kuhl et al 13 and Robert S et al 14 observed the lowest value at 2 hours of age, and mostly (83%) occurred within first 4 hours of age described by Lin and Ho 15 . Clinically, 2 hours levels of blood glucose are predictive of later hypoglycemia that may require repeat testing 16 . We did not examine the blood glucose at 2 hours and glucose level was done irrespective of feeding status, as we did follow the existing SCABU protocol. Hypoglycemia might be more frequent or severe if glucose estimation could have been done pre-feed and also at 2 hours of life.
Most IDMs have asymptomatic hypoglycemia 4 . The predominance (93.3%) of asymptomatic hypoglycemia in present study is consistent with previously reported studies 14, 15 . However, the absence of overt symptoms at low blood glucose levels does not rule out central nervous system injury 5 . This elevated prevalence of asymptomatic neonatal hypoglycemia in IDMs stress the importance of systematic glucose monitoring at risk babies to prevent severe and recurrent hypoglycemia.of these neonates.
Neonatal hypoglycemia is associated with poor psychoneurological development. Blood glucose should be maintained above 2.6 mmol/l to ensure normal neural function 10 .
Measuring HbA 1C % is considered as the gold standard for monitoring metabolic control in diabetes. A normal non-diabetic HbA1 C is 3. 21 .
On the other hand, Taylor et al 22 showed that there was no correlation between neonatal hypoglycemia and HbA1c levels at any point in pregnancy or with mean pregnancy HbA1c levels. Stenninger et al 23 in his study of 59 mothers with insulin-treated diabetes, showed that neonatal hypoglycemia could still occur despite well controlled diabetes. We also examined the relationship by correlation analysis between maternal HbA1c and blood glucose level of IDMs at 4 hours of age , where a significant negative correlation was observed (r = -0.422, P= 0.001) which is in agreement with the studies done by Ylinen K et al 20 and Cooper et al 24 .
